Omnicell Inc (FRA:OC9)
€ 45 0.6 (1.35%) Market Cap: 2.07 Bil Enterprise Value: 2.10 Bil PE Ratio: 0 PB Ratio: 1.77 GF Score: 71/100

Omnicell Inc Investor and Analyst Day at the Annual ASHP Midyear Meeting Transcript

Dec 10, 2019 / 04:00PM GMT
Release Date Price: €72 (-0.69%)
Peter J. Kuipers
Omnicell, Inc. - Executive VP & CFO

Good morning, everyone. Welcome to the Omnicell Investor and Analyst Day at the ASHP mid-year with you. It's good to see everyone in the room. So welcome to the

(technical difficulty)

this morning will include forward-looking statements

(technical difficulty)

this meeting is also webcast live. We will post a recording of today's webcast and a copy of the presentation in the Investor Relation section of our website at omnicell.com.

Let's now move to our agenda. Agenda for today is as follows: first, Randall Lipps, Omnicell's Chairmen, President, CEO and Founder, will give an update on our mission and discuss our purpose, strategy and priorities; next, Scott Seidelmann, Omnicell's Chief Commercial Officer, will discuss interface and medication management and the 3 areas of growth, starting with point-of-care and opportunities we're seeing in central pharmacy. It's how our customers drive better outcomes, fee automation, analytics and services. This is followed by a note for you, of the Autonomous

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot